Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2650 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Mylan wins FDA approval for fluoxetine capsules

Fluoxetine capsules, indicated for the treatment of premenstrual dysphoric disorder are the generic version of Eli Lilly’s Sarafem Pulvules capsules. Currently, Mylan has 112 abbreviated new drug applications

Pharming signs licensing agreement with Aslan Group

The companies have previously concluded a commercialization and supply agreement for the marketing and distribution of food or food supplements containing Pharming’s human lactoferrin product (hLF). Under the

SuperGen names new chief scientific officer

Dr Bearss will continue to lead SuperGen’s discovery and preclinical development strategies and execution as SuperGen continues to accelerate the discovery and advancement into the clinic of novel

Genzyme and ICGEB form collaboration

The collaboration between Genzyme and the International Center for Genetic Engineering and Biotechnology (ICGEB) will initially focus on the development of new, improved treatments for malaria. ICGEB and